A Study of Lobaplatin/Etoposide With or Without Anlotinib Maintenance Therapy in Patients With ES-SCLC
Clinical trial NCT03700359 · UNKNOWN
Trial details
- NCT number
- NCT03700359
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-01
- Primary completion
- 2020-11-29
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.